FDA Determines Regulatory Review Period for ACOVA Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for ACOVA, a pharmaceutical company, in accordance with federal regulations, following the submission of a patent extension application to the US Patent and Trademark Office (USPTO)